NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 18 min ago

Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards

Mon, 2017-04-24 03:14
Notice NOT-HS-17-014 from the NIH Guide for Grants and Contracts

Notice of Correction to Instructions for Application Submission for PAR-17-238 "Developmental Centers for AIDS Research (P30)"

Mon, 2017-04-24 03:04
Notice NOT-AI-17-025 from the NIH Guide for Grants and Contracts

Notice of Correction to Instructions for Application Submission for PAR-17-237 "Centers for AIDS Research (P30)"

Mon, 2017-04-24 02:59
Notice NOT-AI-17-024 from the NIH Guide for Grants and Contracts

Advancing Conformance with the Voluntary National Retail Food Regulatory Program Standards (VNRFRPS) (U18)

Mon, 2017-04-24 02:55
Notice NOT-FD-17-009 from the NIH Guide for Grants and Contracts

Presolicitation Notice: Request for Proposals (RFP) N01PC65003-74 "Surveillance, Epidemiology, and End Results (SEER) Program"

Mon, 2017-04-24 02:44
Notice NOT-CA-17-053 from the NIH Guide for Grants and Contracts

Notice of Change in Award Budget for RFA-AA-17-016 "Alcohol-PTSD Comorbidity: Preclinical Studies of Models and Mechanisms (R01)"

Fri, 2017-04-21 03:44
Notice NOT-AA-17-003 from the NIH Guide for Grants and Contracts

Limited Competition: Data Coordinating Center for Type 1 Diabetes TrialNet (UC4)

Fri, 2017-04-21 03:41
Funding Opportunity RFA-DK-17-507 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator of the Data Coordinating Center (DCC) that is currently supporting the research being performed by the complex and effective Type 1 Diabetes TrialNet network. This FOA will support the design and conduct of new-onset trials (as selected by the TrialNet Steering Committee) aimed at preservation of insulin-producing cells in individuals with new-onset diabetes.

NIH Director's Transformative Research Awards (R01)

Thu, 2017-04-20 10:01
Funding Opportunity RFA-RM-17-007 from the NIH Guide for Grants and Contracts. The NIH Director's Transformative Research Award complements NIHs traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected. Projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research. The NIH Directors Transformative Research Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Developing New Clinical Decision Support to Disseminate and Implement Evidence-Based Research Findings (R18)

Thu, 2017-04-20 09:46
Funding Opportunity PA-17-261 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites R18 grant applications for developing new clinical decision support (CDS) to facilitate the dissemination and implementation of evidence-based research findings. The purposes of this FOA are to develop new, reliable, valid, and usable CDS from evidence-based research findings and then demonstrate its effectiveness to improve care in clinical practice.

Scaling Established Clinical Decision Support to Facilitate the Dissemination and Implementation of Evidence-Based Research Findings (R18)

Thu, 2017-04-20 09:44
Funding Opportunity PA-17-260 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites R18 grant applications for research projects to scale and spread existing clinical decision support (CDS) to facilitate the dissemination and implementation of evidence-based research findings into clinical practice. The purposes of this FOA are to extend the implementation ("scale") and evaluation of well-established and effective CDS beyond the initial clinical setting or institution in which the CDS was originally developed and implemented, thereby extending the impact on clinical practice.

NIH Director's Pioneer Award Program (DP1)

Thu, 2017-04-20 08:50
Funding Opportunity RFA-RM-17-005 from the NIH Guide for Grants and Contracts. The NIH Directors Pioneer Award complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Pages